These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [A case of graft-versus-host disease following red cell concentrate (MAP-CRC) transfusion]. Nakamoto T; Nishi S; Shindoh M; Hayashi M; Yukioka H; Fujimori M; Maekawa N Masui; 1995 Sep; 44(9):1261-4. PubMed ID: 8523663 [TBL] [Abstract][Full Text] [Related]
6. Transfusion-associated graft-versus-host disease in a renal transplant recipient. Adeva Andany M; Martínez W; Arnal F; Yebra T; García Falcón T; Rodríguez Lozano I; Lorenzo D; Alonso A Nephrol Dial Transplant; 1994; 9(2):196-8. PubMed ID: 8190340 [No Abstract] [Full Text] [Related]
7. Severe combined immunodeficiency in a Malaysian child. Noh LM; Amir HL; Hung LC; Zulkifli I; Nasuruddin BA Med J Malaysia; 1997 Mar; 52(1):88-91. PubMed ID: 10968061 [TBL] [Abstract][Full Text] [Related]
8. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force. Transfus Med; 1996 Sep; 6(3):261-71. PubMed ID: 8885157 [No Abstract] [Full Text] [Related]
9. The role of inflammation in respiratory impairment during Pneumocystis carinii pneumonia. Hahn PY; Limper AH Semin Respir Infect; 2003 Mar; 18(1):40-7. PubMed ID: 12652453 [TBL] [Abstract][Full Text] [Related]
10. Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells. Triulzi D; Duquesnoy R; Nichols L; Clark K; Jukic D; Zeevi A; Meisner D Transfusion; 2006 Jun; 46(6):885-8. PubMed ID: 16734803 [TBL] [Abstract][Full Text] [Related]
11. Post-transfusion acute graft versus host disease in a 17-year-old girl with a malignant mesenchymal tumor--report of a case. Utkan G; Buyukcelik A; Demir O; Sanli H; Pamir A Acta Med Austriaca; 2003; 30(5):138-41. PubMed ID: 15055161 [TBL] [Abstract][Full Text] [Related]
12. [Indications for irradiated blood components: dose and side effects]. Eiermann TH Beitr Infusionsther; 1993; 31():70-3. PubMed ID: 7693267 [TBL] [Abstract][Full Text] [Related]
14. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection. Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367 [TBL] [Abstract][Full Text] [Related]
15. Toxic serum levels of tacrolimus after topical administration in an infant with severe cutaneous graft-versus-host disease. Prot-Labarthe S; Therrien R; Champagne MA; Duval M; Joubert C Bone Marrow Transplant; 2007 Aug; 40(3):295-6. PubMed ID: 17549052 [No Abstract] [Full Text] [Related]
16. [Chronic posttransfusion graft-vs-host disease in a patient with non-Hodgkin's lymphoma]. García Gala JM; Ramírez Páyer A; Rayón C; Rodríguez Vicente P; Rosón C; Blanco C Sangre (Barc); 1993 Dec; 38(6):489-91. PubMed ID: 8171385 [TBL] [Abstract][Full Text] [Related]
18. Fatal graft-vs.-host reaction following transfusion of allogeneic blood and plasma in infants with combined immunodeficiency disease. Park BH; Good RA; Gate J; Burke B Transplant Proc; 1974 Dec; 6(4):385-7. PubMed ID: 4155155 [No Abstract] [Full Text] [Related]
19. Transfusion medicine--2003: a comprehensive review, Part II. Menitove JE Mo Med; 2003; 100(5):530-4; quiz 534-5. PubMed ID: 14601446 [No Abstract] [Full Text] [Related]